Cybin Inc. (NASDAQ:HELP)

CA · Delayed Price · Currency is USD

12.97+0.13 (+1.01%)

Market Cap	803.93M+119.8%
Revenue (ttm)	0
Net Income	-183.27M-49.1%
EPS	-5.51+7.2%
Shares Out	61.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,146,197
Open	13.27
Previous Close	12.84
Day's Range	12.61 - 13.52
52-Week Range	3.76 - 14.35
Beta	0.56
Analysts	Buy
Price Target	15.50(+19.51%)
Earnings Date	Nov 12, 2026

Full Chart

Alerts Compare

About HELP

Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.

Address

100 King Street West, Suite 5600, Toronto, ON, M5X 1C9, CA

Market Cap

804 million

Employees

100

Industrial Classification

Medical - Pharmaceuticals

Latest News

InsiderBuyingOur analysisTwo SpaceX Directors Are Funding the Push to Approve MDMAAntonio Gracias put $25 million into the MDMA developer the FDA rejected. The listed psychedelics stocks show almost no insider buying — bar one.Sep 11, 2026

1 Day

+1.17%

5 Days

+9.99%

1 Month

+28.74%

6 Months

+141.45%

1 Year

+119.80%

$HELP stock is featured in our Insider Trades datasets.

→ All Stock Lists

Whale Activity →

Recently reported changes in HELP holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by HELP's directors and management

No SEC Form 4 activity for HELP in the last 5 quarters.

Source: SEC EDGAR (Form 4)

Corporate Lobbying

HELP Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New HELP patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to HELP from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in HELP

ETF	Est. Holding Size
PSILAdvisorShares Psychedelics ETF	$4.88M
QQQSInvesco NASDAQ Future Gen 200 ETF	$322.36K
TNXTT. Rowe Price Innovation Leaders ETF	$11.72K

Estimated from each fund’s disclosed top holdings × AUM

HELP Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for HELP yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from HELP’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

No Form 4 filings in the last 90 days.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.